On the prevention of viral transmitted infections in plasma products.
A short review is given on screening tests and regulatory requirements of viral inactivation for plasma products in the Federal Republic of Germany. Guidelines for blood group determination and blood transfusion and guidelines for plasmapheresis contain the particular directions for blood and plasma donations. The licensing of drugs is regulated by the Drugs Act of 1976. To prevent virus infections the following screening tests are advised: HBs antigen, ALT, and LAV/HTLV-III antibody determination.
D000914:Antibodies, Viral / Q000032:analysis; D001798:Blood Proteins / Q000592:standards*; D001803:Blood Transfusion / Q000592:standards*; D017977:Deltaretrovirus / Q000276:immunology; D005860:Germany, West; D015483:HIV Antibodies; D006801:Humans; D007885:Legislation, Pharmacy; D010956:Plasmapheresis / Q000592:standards*; D011786:Quality Control; D014777:Virus Diseases / Q000097:blood / Q000517:prevention & control* / Q000635:transmission
D000914:Antibodies, Viral; D001798:Blood Proteins; D015483:HIV Antibodies